Daily aspirin reduces risk of ovarian cancer, regardless of genetics

Published Date: 08 Mar 2023

New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.

Read Full News

Latest News

Democrats Press RFK Jr. on an Ethics Agreement Change Involving Law Firm Fees

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

Two Procedures May Yield Similar Symptom Relief for Uterine Fibroids

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

Todays Updates

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.

Experts Examine Biologic Coverage in Asthma and COPD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.

Todays Updates

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD Omid Pourshahid, MD

Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.

Experts Examine Biologic Coverage in Asthma and COPD

Experts Examine Biologic Coverage in Asthma and COPD

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated Marco Meglio

Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.

New Phase 2 Trial Evaluates Fenebrutinib Dosing in Children With Relapsing MS Louie Pasculli

The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.

Latest News

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

News All Time

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

Her Breast MRI Was Approved, but That Didn't Mean Her Insurance Would Pay

High-risk patients face steep, surprise bills for preventive breast MRIs

Lionel Richie Hospitalized; CDC Challenges Measles Toll; Vitamin K Refusals Rise

Health news and commentary gathered by MedPage Today staff

Nurse Who Saved Baby in Pakistan Hospital Fire Wishes She Could Have Saved the Rest

"I acted as a mother," she said

Gloria Steinem on Women's Rights, Abortion Politics, and Being Called the B-Word

And what she thought about Roe v. Wade being overturned

Judge Declares Mistrial in Lindsay Clancy Case

Defense attorney said she was suffering from postpartum psychosis when she strangled her kids

Judge Sends Deadlocked Lindsay Clancy Jurors Home

Foreperson said a single juror won't follow the court's instructions about reasonable doubt

One of the Lindsay Clancy Trial's Most Instructive Moments for Physicians

The author of a medical record doesn't always retain ownership of its meaning

Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy

Trump Pardon Sought for Clancy; Sen. Marshall's Medical Debt Suits; Lasker Winners

Health news and commentary gathered by MedPage Today staff

An Appeals Court Is Considering a Push to Restrict Most Common Abortion Method

The political situation is tricky for President Trump

Ectopic Pregnancy Deaths Have Nearly Doubled. It's Worse in Abortion-Ban States.

"This is a potentially profound consequence of the regulation," said one abortion policy expert

Residency Software Developer Sues Doctor Who Helped Launch a Competing Product

AAMC-partnered Thalamus goes after key players in ResidencyCAS

Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half

Problem is "eminently solvable," says president of Healthy Moms, Healthy Babies America

Recommended News For You

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Risk of a second cancer after early breast cancer is low, say new findings

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

Decrease seen in in situ breast cancer since 2009

Researchers find distinct cell receptors with the potential for new treatments.

Pollution exposure may affect lung cancer in women who have never smoked

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

Recommended Articles For You

Spatial Clonal Architecture Genomics in Solid Tumor Evolution 

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies 

Integrated Trends in Hematology for Modern Medicine 

A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scholastic performance is a key concern for young cancer patients, study finds

2.

Laser Therapy Shows Promise for Brain Tumors

3.

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

4.

Only 1 in 4 Eligible Adults Receive Lung Screening

5.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

1.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

2.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

3.

Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances

4.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

5.

Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Hands-on Workshop: Hematology

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot